147 related articles for article (PubMed ID: 24480967)
41. Generation of Spinal Motor Neurons from Human Pluripotent Stem Cells.
Santos DP; Kiskinis E
Methods Mol Biol; 2017; 1538():53-66. PubMed ID: 27943183
[TBL] [Abstract][Full Text] [Related]
42. Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.
Liu B; Chen F; Wu Y; Wang X; Feng M; Li Z; Zhou M; Wang Y; Wu L; Liu X; Liang D
Oncotarget; 2017 Jun; 8(25):40791-40803. PubMed ID: 28388559
[TBL] [Abstract][Full Text] [Related]
43. Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.
Asai A; Aihara E; Watson C; Mourya R; Mizuochi T; Shivakumar P; Phelan K; Mayhew C; Helmrath M; Takebe T; Wells J; Bezerra JA
Development; 2017 Mar; 144(6):1056-1064. PubMed ID: 28275009
[TBL] [Abstract][Full Text] [Related]
44. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
45. Stem cell therapy for acute respiratory distress syndrome: a promising future?
Horie S; Masterson C; Devaney J; Laffey JG
Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
[TBL] [Abstract][Full Text] [Related]
46. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
[TBL] [Abstract][Full Text] [Related]
47. Differential effects of acellular embryonic matrices on pluripotent stem cell expansion and neural differentiation.
Yan Y; Martin LM; Bosco DB; Bundy JL; Nowakowski RS; Sang QX; Li Y
Biomaterials; 2015 Dec; 73():231-42. PubMed ID: 26410789
[TBL] [Abstract][Full Text] [Related]
48. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
[TBL] [Abstract][Full Text] [Related]
49. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
Bhonde RR; Sheshadri P; Sharma S; Kumar A
Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
[TBL] [Abstract][Full Text] [Related]
50. A plethora of human pluripotent stem cells.
Gao L; Thilakavathy K; Nordin N
Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972
[TBL] [Abstract][Full Text] [Related]
51. Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.
Varela I; Karagiannidou A; Oikonomakis V; Tzetis M; Tzanoudaki M; Siapati EK; Vassilopoulos G; Graphakos S; Kanavakis E; Goussetis E
Cell Reprogram; 2014 Dec; 16(6):447-55. PubMed ID: 25354259
[TBL] [Abstract][Full Text] [Related]
52. Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement.
Peng KY; Lee YW; Hsu PJ; Wang HH; Wang Y; Liou JY; Hsu SH; Wu KK; Yen BL
Oncotarget; 2016 Jul; 7(28):43949-43959. PubMed ID: 27304057
[TBL] [Abstract][Full Text] [Related]
53. Does soft really matter? Differentiation of induced pluripotent stem cells into mesenchymal stromal cells is not influenced by soft hydrogels.
Goetzke R; Franzen J; Ostrowska A; Vogt M; Blaeser A; Klein G; Rath B; Fischer H; Zenke M; Wagner W
Biomaterials; 2018 Feb; 156():147-158. PubMed ID: 29197223
[TBL] [Abstract][Full Text] [Related]
54. Impaired neural differentiation potency by retinoic acid receptor-α pathway defect in induced pluripotent stem cells.
Hou PS; Huang WC; Chiang W; Lin WC; Chien CL
Cell Reprogram; 2014 Dec; 16(6):467-76. PubMed ID: 25364979
[TBL] [Abstract][Full Text] [Related]
55. Making gametes from alternate sources of stem cells: past, present and future.
Bhartiya D; Anand S; Patel H; Parte S
Reprod Biol Endocrinol; 2017 Nov; 15(1):89. PubMed ID: 29145898
[TBL] [Abstract][Full Text] [Related]
56. Inducing goat pluripotent stem cells with four transcription factor mRNAs that activate endogenous promoters.
Chen H; Zuo Q; Wang Y; Song J; Yang H; Zhang Y; Li B
BMC Biotechnol; 2017 Feb; 17(1):11. PubMed ID: 28193206
[TBL] [Abstract][Full Text] [Related]
57. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
58. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
Trivedi P; Hematti P
Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
[TBL] [Abstract][Full Text] [Related]
59. Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury.
Imberti B; Tomasoni S; Ciampi O; Pezzotta A; Derosas M; Xinaris C; Rizzo P; Papadimou E; Novelli R; Benigni A; Remuzzi G; Morigi M
Sci Rep; 2015 Mar; 5():8826. PubMed ID: 25744951
[TBL] [Abstract][Full Text] [Related]
60. Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives.
Aggarwal S; Moggio A; Bussolati B
Stem Cells Transl Med; 2013 Dec; 2(12):1011-9. PubMed ID: 24167320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
